Invitrogen Corporation (IVGN) And Blue Heron Biotechnology Enter Into Strategic Development And Distribution Relationship  
12/12/2006 12:11:22 PM

CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN), a global leader in life sciences, today announced they have entered into a strategic development and distribution relationship with Blue Heron Biotechnology. Invitrogen will invest in Blue Heron in exchange for worldwide rights to distribute Blue Heron’s custom gene synthesis services. Under the terms of the agreement, Invitrogen will become the exclusive worldwide distributor of Blue Heron’s synthetic genes. The financial terms of the agreement were not disclosed.